Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.
| Last: | $0.615 |
|---|---|
| Change Percent: | 2.01% |
| Open: | $0.615 |
| Close: | $0.6029 |
| High: | $0.615 |
| Low: | $0.615 |
| Volume: | 1,090 |
| Last Trade Date Time: | 03/09/2026 09:30:00 am |
| Market Cap: | $28,989,551 |
|---|---|
| Float: | 36,461,505 |
| Insiders Ownership: | 0.3% |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.barinthusbio.com |
| Country: | GB |
| City: | Germantown |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Barinthus Biotherapeutics plc American Depositary Shares (NASDAQ: BRNS).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
